Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Head
Job title: Professor of Surgery in the Division of Vascular & Endovascular Surgery
Dr Peter A Schneider is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. He received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco. Dr Schneider was the founding member and chief of the Division of Vascular… View more
Simon Stewart
Prof Simon Stewart,FESC, FAHA, FHFA,is a National Health & Medical Research Council of Australia (NHMRC) Senior Principal Research Fellow based at Torrens University Australia. A cardiovascular nurse scientist and health services researcher, Prof Stewart is internationally recognised for his efforts to understand and respond to an evolving epidemic of chronic heart disease across the globe… View more
Felipe Garza
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Head of Cardio-oncology
DrFelipe Garza isHead of Cardio-oncology atOncare Treatment Center, San Pedro Garza Garcia, MX. Dr Garza is also president of the Mexican chapter of IC-OS. His research interests include cardiac imaging and surveillance in patients with positive HER-2 breast cancer. View more
Renato D Lopes
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Renato D Lopes is currently the Director of Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group. His primary research interests include investigating the impact and outcomes of atrial fibrillation complicating acute coronary syndromes. Dr Lopes completed his clinical training at the Federal University of São Paulo, and his… View more
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 10 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention
DELINEATE-Regurgitation: AI Accurately Classifies Valvular Regurgitation and Predicts MR Progression
Added: 6 months ago Source:  Radcliffe Cardiology
The classification and risk stratification of aortic, mitral, and tricuspid regurgitation present significant clinical challenges, with diagnosis often subject to interobserver variability. The DELINEATE-Regurgitation study investigated a novel artificial intelligence (AI) system designed to provide accurate, reproducible echocardiographic assessment of valvular regurgitation and to stratify the… View more

Digital Health

Guidelines & Statements
Recurrent MSSA Pericarditis in a Patient with SARS-CoV-2 and Bacteremia
Author(s): Deitrich Gerlt , Sharon Mathai , Kristopher Aten , et al Added: 12 months ago

Imaging & Diagnostics

Pericardium Disorders
Sex and Gender Differences in Fibromuscular Dysplasia
Author(s): Marianne H Khoury , Sims Hershey , Rebecca M LeLeiko Added: 1 year ago

Demographic

Imaging & Diagnostics